等待開盤 07-17 09:30:00 美东时间
+2.140
+2.59%
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务,助力上市公司传播ESG理念,提升ESG可持续发展表现。点击查看【 ESG评级中...
今天 11:46
Globant is partnering with Suntory Global Spirits to build a generative AI-powered Commercial Insights AgentWith the Agent, Suntory Global Spirits employees can access data insights and self-service intelligence,
07-08 03:08
Throughout the last three months, 12 analysts have evaluated Globant (NYSE:GLOB...
06-26 20:00
/摘要 存量核心品种竞争格局良好,后续销售表现有望持续超预期: 公司核心品种特比澳作为指南重点推荐、目前全球唯一获批用于CIT适应症的特异性升板药物...
06-25 13:49
The latest announcement is out from Globant SA ( ($GLOB) ). On June 18, 2025, G...
06-24 04:47
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1139478829918380033.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim:维持Metsera(MTSR)"买入"评级,目标价从56美元升至62美元</p> <p>• 摩根大通:维持Avidity Biosciences(RNA)"超配"评级,目标价从57美元升至59美元</
06-11 09:43
Throughout the last three months, 10 analysts have evaluated Globant (NYSE:GLOB...
06-11 03:02
Guggenheim analyst Jonathan Lee reiterates Globant (NYSE:GLOB) with a Buy and maintains $125 price target.
06-10 23:25
潜在涨幅300.0%!HC Wainwright & Co.:Armata Pharmaceuticals获机构升目标价至9美元,维持"买入"评级
05-21 16:44
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1131517965561573377.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.:维持Armata Pharmaceuticals(ARMP)"买入"评级,目标价从7美元升至9美元</p> <p>• 瑞银:维持爱芬奇(ANF)"买入"评级,目标价从115美
05-20 09:28